[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100630094":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":29,"locations":35,"responsibleParty":58,"collaborators":10,"id":61,"slug":62,"hasResults":63,"nctId":64,"briefTitle":65,"officialTitle":66,"acronym":10,"eligibilityCriteria":67,"healthyVolunteers":63,"sex":68,"minAge":69,"maxAge":10,"enrollmentInfo":70,"targetDuration":10,"studyType":73,"phases":10,"briefSummary":74,"conditions":75,"keywords":10,"overallStatus":38,"whyStopped":10,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},{"fullName":5,"class":6},"Mayo Clinic","OTHER",[8,13,16],{"label":9,"type":10,"description":10,"interventionNames":11},"Aortic Intervention",null,[12],"Diagnostic Test: Echocardiogram",{"label":14,"type":10,"description":10,"interventionNames":15},"Mitral Intervention",[12],{"label":17,"type":10,"description":10,"interventionNames":18},"Tricuspid intervention",[12],[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":10},"DIAGNOSTIC_TEST","Echocardiogram","An echocardiogram will be performed during the patient's routinely scheduled right heart catheterization.",[9,14,17],[26],{"name":27,"affiliation":5,"role":28},"Barry Borlaug, MD","PRINCIPAL_INVESTIGATOR",[30],{"name":31,"role":32,"phone":33,"phoneExt":10,"email":34},"Annabelle Fuenffinger","CONTACT","507-422-3801","fuenffinger.annabelle@mayo.edu",[36],{"facility":37,"status":38,"city":39,"state":40,"zip":41,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"Mayo Clinic in Rochester","RECRUITING","Rochester","Minnesota","55905","United States","US",{"type":45,"coordinates":46},"Point",[47,48],-92.4699,44.02163,{"lat":48,"lon":47},[51,54,57],{"name":52,"role":32,"phone":53,"phoneExt":10,"email":10},"Dr. Borlaug's Research Team","(507) 255-2200",{"name":27,"role":32,"phone":55,"phoneExt":10,"email":56},"(507) 255-1051","Borlaug.Barry@mayo.edu",{"name":27,"role":28,"phone":10,"phoneExt":10,"email":10},{"type":28,"investigatorFullName":59,"investigatorTitle":60,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Barry Borlaug","Principal Investigator","100630094","a-study-of-clinical-implications-of-pulmonary-vascular-disease-in-valvular-heart-disease-100630094",false,"NCT07483203","A Study Of Clinical Implications Of Pulmonary Vascular Disease In Valvular Heart Disease","Clinical Implications of Pulmonary Vascular Disease in Valvular Heart Disease","Inclusion Criteria:\n\n* ≥18 years old; AND\n* Scheduled for valve procedures\n\nExclusion Criteria:\n\n* Congenital heart disease (except for bicuspid aortic valve), OR\n* Carcinoid heart disease, OR\n* Valvular mass, OR\n* Endocarditis, OR\n* Any other condition that, in the opinion of the investigator, would impair their ability to complete the study","ALL","18 Years",{"count":71,"type":72},600,"ESTIMATED","OBSERVATIONAL","The purpose of this study is to characterize pulmonary hemodynamic profiles, with a focus on PVR subtypes, in patients with left-sided valvular heart disease undergoing aortic or mitral valve intervention, and to identify patterns predicting reversibility of TR and RV dysfunction.",[76,77],"Pulmonary Vascular Disease","Valvular Heart Disease","2026-06-16",{"date":80,"type":81},"2026-06-18","ACTUAL",{"date":83,"type":81},"2026-04-28",{"date":85,"type":72},"2028-05",{"name":5,"class":6},1]